NCT07635290

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06-03Est. Completion: 2027-06-30

Enrollment target: 26 participants

Locations

Glioma

This study (1438-0003) is open to adults with a tumour in the brain that is positive for the tumour marker delta-like 3 …

Orange, United StatesEst. completion Aug 9, 2027

Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerAdvanced Solid Tumors Harboring the KRAS G12C Mutation

The purpose of this study is to allow continued access to opnurasib (JDQ443) to participants who are benefitting from tr…

Seoul, South KoreaEst. completion Jun 15, 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.